Corpus Intelligence IC Memo — ADVENTHEALTH CONNERTON 2026-04-27 01:02 UTC
IC Memo — ADVENTHEALTH CONNERTON
Investment Committee Memorandum | FL | 77 beds | Grade C | EBITDA uplift $3.2M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 102026

ADVENTHEALTH CONNERTON

LOCATIONPASCO, FL·BEDS77·AS OFApril 27, 2026
C
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

ADVENTHEALTH CONNERTON is a 77-bed suburban community hospital in PASCO, FL with $43.7M in net patient revenue and a -11.1% operating margin. The hospital serves a payer mix of 38.4% Medicare, 0.3% Medicaid, and 61.4% commercial.

Thesis: Turnaround. Our ML models identify $3.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -11.1% to -3.8% (+736bps).

Net Revenue HCRIS$43.7M
Current EBITDA COMPUTED$-4.9M
Operating Margin COMPUTED-11.1%
Occupancy HCRIS97.4%
Revenue / Bed COMPUTED$567K
Net-to-Gross HCRIS20.0%
Distress Probability ML36.7%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
120
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of -11.1% places it below the state median. Among 120 size-comparable peers (38-154 beds), the median margin is 3.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (38-154), prioritizing same-state peers. 120 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ADVENTHEALTH CONNERTON (Target)FL77$43.7M-11.1%
WEST KENDALL BAPTIST HOSPITALFL127$361.6M18.5%
ADVENTHEALTH PALM COASTFL99$285.7M8.1%
NEMOURS CHILDRENS HOSPITALFL130$268.7M-10.2%
DOCTORS HOSPITALFL130$250.0M0.9%
ADVENTHEALTH ZEPHYRHILLSFL149$207.1M-0.8%
ADVENTHEALTH DELANDFL142$197.1M2.8%
ASCENSION SACRED HEART BAYFL126$192.1M-6.7%
ASCENSION SACRED HEART EMERALDFL80$187.9M16.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$917K+210bp18mo
Cost to Collect4.5%2.5%$873K+200bp12mo
Denial Rate Reduction12.0%6.5%$864K+198bp12mo
A/R Days Reduction5200.0%3800.0%$531K+122bp9mo
Clean Claim Rate88.0%96.0%$28K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$917K
Cost to Collect
$873K
Denial Rate Reduction
$864K
A/R Days Reduction
$531K
Clean Claim Rate
$28K
Total EBITDA Uplift$3.2M
Current EBITDA$-4.9M
+ RCM Uplift+$3.2M
Pro Forma EBITDA$-1.6M
Current Margin-11.1%
Pro Forma Margin-3.8%
WC Released (1x)$1.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-7.5M$85K0.00x-100.0%
Base (11x exit)10.0x11.0x$-7.5M$-2.3M0.00x-100.0%
Bull Case9.0x11.0x$-6.7M$5.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-6.7M$4.4M0.00x-100.0%
Bear Case11.0x10.0x$-8.2M$-13.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-8.2M$-17.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 120 hospitals with 38-154 beds
  • Same-state prioritization (n=121)
  • Comp margins: P25=-8.7% / P50=3.1% / P75=11.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.